ArticleOncology letters2016

Bortezomib-based chemotherapy to treat refractory angioimmunoblastic T-cell lymphoma: A case report and review of the literature.

Hua-Ping DU et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.